Non-Profit Advocates for Affordable Prescription Drug Prices Call on Congress to Increase Competition and Hold Big Pharma Accountable In case you missed it, Tahir Amin and Priti Krishtel, co-executive directors of the Initiative for Medicines, Access & Knowledge (I-MAK), published an op-ed in The Hill calling on Congress to lower prescription drug prices by holding
New Matrix Global Advisors Report Shines Light on Cost of Big Pharma’s Patent Abuse A new report released on Thursday by Matrix Global Advisors and commissioned by the Coalition for Affordable…
Broad Majorities Reject Big Pharma’s Blame Game and Want Policymakers to Advance Market-Based Solutions to Crack Down on Big Pharma’s Egregious Pricing and Anti-Competitive Practices For…
Brand Name Drug Companies Increase Prices on Treatments for Serious Conditions Like Cancers, Autoimmune Conditions, Seizures and More For Immediate Release Contact: Jon Conradi 860-235-3884…
Brand Name Drug Companies Continue Seeking to Price-Gouge COVID-19 Treatments and Vaccines Ahead of Transition to Commercial Market For Immediate Release Contact: Jon Conradi 860-235-3884…
Analysis Finds Drug Companies Increased Prices Faster Than the Rate of Inflation on 70 of the 93 Best-Selling Part B Prescription Drugs In case you missed it…
Brand Name Drug Companies Setting Egregious Prices on New Products Not Justified by Clinical Value for Patients In case you missed it, Reuters released a new analysis that found the median annual…
Congressional Probe Concludes Biogen Set Egregious Price Tag on Aduhelm to Maximize Profits, Knew Price Tag Could Lead to Affordability Issues for Patients In case you missed it…
Brand Name Drug Companies Maintain Business-as-Usual Approach to Price-Gouging the American People at the Start of 2023 For Immediate ReleaseContact: Jon [email protected]…
Get the Facts on Big Pharma’s Year of Out-of-Control Launch Prices, Price Hikes, Anti-Competitive Tactics and Massive Spending on a Debunked Blame Game Despite unprecedented scrutiny of Big…